Risk of subclinical atherosclerosis across metabolic transition in individuals with or without fatty liver disease: a prospective cohort study

BACKGROUND: Metabolic dysfunction is a major determinant in the progression of fatty liver disease. It is pivotal to evaluate the metabolic status and subsequent transition in fatty liver population and to identify the risk of subclinical atherosclerosis. METHODS: The prospective cohort study includ...

Descripción completa

Detalles Bibliográficos
Autores principales: Xin, Zhuojun, Huang, Jiaojiao, Cao, Qiuyu, Wang, Jialu, He, Ruixin, Hou, Tianzhichao, Ding, Yi, Lu, Jieli, Wang, Tiange, Zhao, Zhiyun, Wang, Weiqing, Ning, Guang, Xu, Min, Bi, Yufang, Xu, Yu, Li, Mian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10007748/
https://www.ncbi.nlm.nih.gov/pubmed/36899397
http://dx.doi.org/10.1186/s12986-023-00734-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10007748/
https://www.ncbi.nlm.nih.gov/pubmed/36899397
http://dx.doi.org/10.1186/s12986-023-00734-3

Ejemplares similares